COURTNEY GEARHART: Open Payments
NPI 1982911871 · BROWNSTOWN TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 16 payments from 9 companies in 2025. Trend: 2023 $454 · 2024 $482 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: Wegovy, CAMZYOS, NEXLETOL, FARXIGA, LEQVIO, LifeVest, REPATHA, JARDIANCE.
Industry payments across MI — which companies pay providers there.
